Replies to post #197246 on Biotech Values

[DewDiligence]

ZTS acquires NVET for $6.72/sh in cash—a 66% premium to yesterday’s close:

http://finance.yahoo.com/news/zoetis-acquire-nexvet-biopharma-innovator-132400773.html

The nominal deal value is $85M.

ZTS is the 2013 animal-health spin-off from PFE (#msg-84067350).

p.s. NVET was the answer to a difficult quiz on this board (#msg-118803169).